3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Thyroid Neoplasms
1
Rectal Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Neuroendocrine Tumors
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Myocarditis
1
Multiple Pulmonary Nodules
1
Liver Metastases
1
Hematologic Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Neuroendocrine
1
Carcinoma, Lobular
1
Breast Neoplasms
1
Interventions
Doxorubicin
14
Specimen Handling
12
pembrolizumab
11
Magnetic Resonance Spectroscopy
10
Biopsy
10
Cyclophosphamide
9
X-Rays
7
Radiotherapy
7
Ifosfamide
7
Phantoms, Imaging
6
Nivolumab
6
Gemcitabine
6
tazemetostat
5
liposomal doxorubicin
5
Temozolomide
5
Radiation
5
palbociclib
4
fludarabine
4
atezolizumab
4
Nuclear Medicine Department, Hospital
4
Irinotecan
4
larotrectinib
3
cabozantinib
3
Trabectedin
3
Surveys and Questionnaires
3
Radiation Dose Hypofractionation
3
Proton Therapy
3
Ipilimumab
3
Carboplatin
3
Bevacizumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
Positron Emission Tomography Computed Tomography
×
90 days
×
Clear all
No trials found.